Member Info for PhatStyle4321

Teething issues are common in new ventures however overall this business is the exact same one as it was a year ago, probably even better as the first product is producing revenue and actually works. I believe some kind of update would be a good idea for the company to release to give guidance on Axis revenue, Croda and the oral programme.

From Elrics interview with Stuart, Stuart did mention that all was going fine. I will be trying to get more funds together to top up at these silly low prices

I had this on one of my shipments, however if you call them they will revoke the import tax, Fedex get confused with it

Great discussion everyone, nice to see the boards full of life once again.

I, myself believe in product and believe in Stuart, the half yearly report states that will 'materially miss' the £1.2m forecast, however alot of marketing has gone into the product since then and who knows what the actual figure will be.

TW has forecasted around £600,000, however my opinion will be north of this, time will tell. However I know that Axis is a small part of the machine. We enter a new month today which brings us 1 month closer to our beloved Croda deal where revenues are anticipated by year end.

This quote from Stuart was golden from me

Stuart quotes ' Moreover, the company remains on track with its commercial strategy and see no reason for the share price decline other than the broader market turmoil which is not Skinbio specific'.

The fact everything is on track means that figures could be a lot higher than the market is anticipating

We may get one end of June however this quote from Stuart really can put the doomongers to bed.

Stuart quotes ' Moreover, the company remains on track with its commercial strategy and see no reason for the share price decline other than the broader market turmoil which is not Skinbio specific'.

As it proves everything is on target

I believe it would be in the best interests for a RNS to state what the revenue figure is by the end of June, I believe that if it isn’t far off the £1.2m forecast then faith would be restored here.

Yes thank you Elric, this will put silent all the scaremongers out there suggesting there is more bad news on the way, great to see Stuart confirming everything is on track.

Surely with this national advertising campaign and influencers, the revenue target shouldn’t be that far behind now !!!

Nicely written article released from Elric today, stating a huge marketing campaign, more details in the article, great play from Stuart. Also confirms from Stuart that there is no bad news in the pipeline and everything is on schedule.

Stuart quotes ' Moreover, the company remains on track with its commercial strategy and see no reason for the share price decline other than the broader market turmoil which is not Skinbio specific'.

Looks like Croda, Oral and everything all going well and to plan.

This advertising campaign will have a national reach and we know the product works, it will be very interesting to see how subscriptions will react to this. I suspect end of June revenue numbers may be alot closer to the £1.2m target than we suspect, especially with both the influencer and national newspaper campaign.

Todays physical copy

Just seen an advert for AxisBiotix in the Dailymail, could this be the start of a national awareness campaign? If so then this could be a game changer, along with the influencers, that’s more like it

Clio, couldn’t have said it better myself, the company definitely needs to get some kind of guidance out as some as they can after end of June. I am sure SA is aware of this, then normality can continue.

I am basing it on the previous target of £1.2m by the end of June.

It was a typo

25-40% will be probably above expectations? Anything higher I will see us stay at this price. Time will tell but the miss altogether hasn’t done well for the short term price here

Everyone has there reasons for investing here, now we all know that Skinbio can rise as quickly as it falls, the story has remained the same apart from the revenue miss? I believe we will all know the severity of this miss by the end of June. I believe that if the miss is between 15-40% then the share price will rise, anything more and we will probably stay the same.

Once Axis has a high enough base then the revenues should really start to roll in.

Croda is also the big winner here with revenues expected by year end.

I totally agree, Stuart knows that another miss here will really send this south, I have faith and from the interviews Stuart is determined to make this good again.

No one knows what the end of June figures will be and what a material miss really means, however how I see it is that if the company were prepared to forecast £1.2m in mid Feb, then i cant see that it would be majorly far from that figure, 25-40% miss would be received very well IMO.

There are many upcoming events that could rocket us back to 50p+, when that time comes folk will be kicking themselves why they didnt buy more at this insane prices.

Hi Ody

This part of the RNS really stands out

‘Through the course of the collaboration, Sederma continues to identify additional potential scientific and marketing claims for the end ingredient. In parallel to the manufacturing scale-up process that Croda are progressing at its facility near Widnes, Sederma is continuing its lab work to further substantiate any additional potential claims.

Croda has engaged with its VIP clients and management continues to anticipate licensed royalty revenue generation by the end of 2022’

Once validated and we know if they are any additional claims this will really enhance the possibilities of how Sederma market Skinbiotix. Croda don’t update Skinbio every week or every month for that matter and will probably only communicate when something is worth communicating.

This for me has always been the golden goose and I believe it’s only a matter of time before good news comes on this front.

No one knows the impact marketing has on sales currently but I suspect there will be an update by the end of June so that investors can quantify the word ‘material’.

Then there’s the oral research which depending on the results could lead to other revenue or collaborations as stated in the RNS.

Patience is required here, something I keep telling myself everyday but I believe in Stuart and know that this will come good as it always has. Remember the story is the same.

I agree with Toyin and it is highly unlikely anything has leaked, it could be a distressed seller by the looks of the trades. No doubt that in the next 3-6 months we will be considerably higher

This is definitely way overdone, I guess no news is good news, investors get bored easy and I believe this is what we are witnessing here, the company will surely update when the time is relevant, patience is key here, day by day I am sure sales from axis grow, and every week that flys by, brings us a week closer to Croda

Not sure why folk keep selling here, very painful to watch but I think this is very overdone

Good debate here everyone, I suspect Stuart is well aware of what the miss has done to sentiment and the share price. It will be very interesting to read the end of June figures. I have my faith in Stuart, if the miss is between 10-35% then I can see the share price shooting up, anything it is to be expected. TW mentioned he predicted £600,000. As one of you stated, the product is fantastic it’s just it isn’t known wide enough.